Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Curex vs Longevixx

Curex
Graded #272

Lower grade

vs+7.3
Longevixx
Graded #109

Higher grade

The verdict

Longevixx takes it — 70.7/100 to 63.4/100.

Longevixx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Longevixx sells lab-informed dosing and cadenced check-ins, publishes no lab price and no lab requirement, and prints “same price, no hidden fees” above a card that rises after month one.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
54
54
Dose & formulationEven
75
75
Clinical oversightLongevixx +19
55
74
Labs & monitoringLongevixx +29
55
84
FulfillmentCurex +11
90
79
Contract termsLongevixx +6
61
67
Curex · left barLongevixx · right bar

The numbers

MetricCurexLongevixx
WeighScore63.4/10070.7/100
GradeCC
Scorecard rank#272#109
Semaglutide$199/mo (compounded oral)$199/mo (standing rate; $149 covers the first month only)
Tirzepatide$199/mo (compounded oral)$299/mo (standing rate)
Coverage45 statesAll 50 states (claimed; the contact page says licensed states only)
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Curex

Graded #272 · C

FDAWarning letter issued to Curex in September 2025. See the FDA warning-letter database.

Strengths

  • LegitScript certified
  • Named entity (Curex, Inc.) with two offices — Miami FL and NYC
  • No membership fee ever
  • Injectable and oral dissolving tablet formats
  • Third-party lab testing via FDA/DEA certified labs

Where it loses points

  • Not available in AK, AR, CT, HI, MA, NM, MO
  • Compounded only — explicitly states 'We don't prescribe Ozempic, Wegovy, Zepbound, or Mounjaro'
  • Primary business is allergy immunotherapy — GLP-1 is a newer vertical
  • FDA issued Curex a warning letter in September 2025; the letter is public in FDA's warning-letter database
Longevixx

Graded #109 · C

Strengths

  • A large priced peptide program list sits beside the GLP-1 lines, so most of the menu carries figures
  • Care coaching, a dietitian visit and physician review are listed as included in every plan at no separate charge
  • Free expedited shipping is quoted with a stated two- to three-day window rather than left vague
  • A same-day clinician call is offered at no extra charge if one is needed
  • Publishes clinical hours of Monday to Friday, 9:00 AM to 5:00 PM

Where it loses points

  • $149 is the first-month semaglutide price and the standing rate is $199, while the homepage floor still reads “from $149/mo”
  • “Same price, all dosages, no hidden fees, everything included” sits directly above a card whose price rises after month one
  • The site markets structured lab work and lab-informed dosing, publishes no lab price, states no lab requirement, and the intake never asked for labs
  • Patient counts and average ratings are published at three different values across the homepage and the funnel, with no review platform named for any of them
  • Checkout claims 24/7 access to the care team against published clinical hours of Monday to Friday, 9 to 5
  • No compounding pharmacy, medical group, clinician or NPI is published anywhere
  • There is no refund policy page and no general refund right

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard